Clinical Trials in Illinois

Showing 5241-5260 of 14,943 trials

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

NCT03942601

This is a prospective, multi-center, pilot feasibility study to document the effects of adventitial delivery of temsirolimus or temsirolimus with dexamethasone sodium phosphate injection, USP, after revascularization of femoropopliteal lesions in symptomatic patients with moderate to severe claudication (Rutherford 2-3) or critical limb ischemia (CLI) with rest pain (Rutherford 4). Subjects will be followed for up to 60 months post index procedure.

Peripheral Arterial Disease

Mercator MedSystems, Inc.10 participantsStarted Oct 2019

Little Rock, Arkansas, United States • Orange, California, United States • San Francisco, California, United States +8 more locations

COMPLETEDPhase 3125 miles

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

The primary objective was to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (\>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.

Prurigo Nodularis

Galderma R&D286 participantsStarted Sep 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +97 more locations

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Find Trials by Condition in Illinois

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Clinical Evaluation of the FilmArray® Global Fever (GF) Panel

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Suicide Treatment Alternatives for Teens

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

Ambispective Clinical Evaluation of Sophono™

TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer